Cargando…

A Potential Role of Cholinergic Dysfunction on Impaired Colon Motility in Experimental Intestinal Chagas Disease

BACKGROUND/AIMS: Chagasic megacolon is caused by Trypanosoma cruzi, which promotes in several cases, irreversible segmental colonic dilation. This alteration is the major anatomic-clinical disorder, characterized by the enteric nervous system and muscle wall structural damage. Herein, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricci, Mayra F, Béla, Samantha R, Barbosa, Joana L, Moraes, Michele M, Mazzeti, Ana L, Bahia, Maria T, Horta, Laila S, Santiago, Helton da C, Cruz, Jader S, Capettini, Luciano dos S A, Arantes, Rosa M E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Neurogastroenterology and Motility 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274474/ https://www.ncbi.nlm.nih.gov/pubmed/35799242 http://dx.doi.org/10.5056/jnm21074

Ejemplares similares

Neuronal Parasitism, Early Myenteric Neurons Depopulation and Continuous Axonal Networking Damage as Underlying Mechanisms of the Experimental Intestinal Chagas' Disease
por: Ricci, Mayra Fernanda, et al.
Publicado: (2020)

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
por: Mazzeti, Ana Lia, et al.
Publicado: (2023)

Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2013)

Participation of Central Muscarinic Receptors on the Nervous Form of Chagas Disease in Mice Infected via Intracerebroventricular with Colombian Trypanosoma cruzi Strain
por: de Assis, Gabriela Maira Pereira, et al.
Publicado: (2021)

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease
por: Assíria Fontes Martins, Tassiane, et al.
Publicado: (2015)

A novel substrate for arrhythmias in Chagas disease
por: Santos-Miranda, Artur, et al.
Publicado: (2021)

Review on Experimental Treatment Strategies Against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2021)

NOD2 receptor is crucial for protecting against the digestive form of Chagas disease
por: Pereira, Nathalie de Sena, et al.
Publicado: (2020)

Trends in Taxonomy of Chagas Disease Vectors (Hemiptera, Reduviidae, Triatominae): From Linnaean to Integrative Taxonomy
por: Alevi, Kaio Cesar Chaboli, et al.
Publicado: (2021)

Negative association between right bundle branch block and inducibility of ventricular tachyarrhythmias in Chagas disease
por: Veloso, Henrique Horta
Publicado: (2014)

Outcome of E1224-Benznidazole Combination Treatment for Infection with a Multidrug-Resistant Trypanosoma cruzi Strain in Mice
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2018)

General anaesthesia-related complications of gut motility with a focus on cholinergic mechanisms, TRP channels and visceral pain
por: Zholos, Alexander V., et al.
Publicado: (2023)

Vascular Kinin B(1) and B(2) Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase
por: Mesquita, Thássio R. R., et al.
Publicado: (2017)

NEW CLASSIFICATION FOR ESOPHAGEAL MOTILITY DISORDERS (CHICAGO CLASSIFICATION VERSION 4.0(©)) AND CHAGAS DISEASE ESOPHAGOPATHY (ACHALASIA)
por: HERBELLA, Fernando Augusto Mardiros, et al.
Publicado: (2022)

An updated and illustrated dichotomous key for the Chagas disease vectors of Triatomabrasiliensis species complex and their epidemiologic importance
por: Dale, Carolina, et al.
Publicado: (2018)

The Chronic Gastrointestinal Manifestations of Chagas Disease
por: Matsuda, Nilce Mitiko, et al.
Publicado: (2009)

Historical Perspectives on the Epidemiology of Human Chagas Disease in Texas and Recommendations for Enhanced Understanding of Clinical Chagas Disease in the Southern United States
por: Garcia, Melissa N., et al.
Publicado: (2015)

Functional Characterization of Cholinergic Receptors in Melanoma Cells
por: Lucianò, Anna Maria, et al.
Publicado: (2020)

Hippocampal-evoked inhibition of cholinergic interneurons in the nucleus accumbens
por: Baimel, Corey, et al.
Publicado: (2022)

GABA(B) Receptor Signaling in the Dorsal Motor Nucleus of the Vagus Stimulates Gastric Motility via a Cholinergic Pathway
por: Cruz, Maureen T., et al.
Publicado: (2019)

Impact of IFN-γ Deficiency on the Cardiomyocyte Function in the First Stage of Experimental Chagas Disease
por: Roman-Campos, Danilo, et al.
Publicado: (2022)

Epidemiological indicators of Chagas disease in the metropolitan region of Salvador, Bahia, Brazil
por: Lanza, Fernanda Cardoso, et al.
Publicado: (2023)

Karyotype Evolution in Triatominae (Hemiptera, Reduviidae): The Role of Chromosomal Rearrangements in the Diversification of Chagas Disease Vectors
por: dos Reis, Yago Visinho, et al.
Publicado: (2023)

Climate and Environmental Changes and Their Potential Effects on the Dynamics of Chagas Disease: Hybridization in Rhodniini (Hemiptera, Triatominae)
por: Ravazi, Amanda, et al.
Publicado: (2023)

Triatoma vitticeps subcomplex (Hemiptera, Reduviidae, Triatominae): a new grouping of Chagas disease vectors from South America
por: Alevi, Kaio Cesar Chaboli, et al.
Publicado: (2017)

Use of Nanocarriers Containing Antitrypanosomal Drugs for the Treatment of Chagas Disease
por: Paiva, Diogo de Freitas, et al.
Publicado: (2023)

Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease
por: Moraes Neto, Roberval Nascimento, et al.
Publicado: (2019)

Cell Therapy in Chagas Disease
por: Campos de Carvalho, Antonio C., et al.
Publicado: (2009)

Fexinidazole: A Potential New Drug Candidate for Chagas Disease
por: Bahia, Maria Terezinha, et al.
Publicado: (2012)

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
por: Perez-Lloret, Santiago, et al.
Publicado: (2016)

Chagas Disease: “The New HIV/AIDS of the Americas”
por: Hotez, Peter J., et al.
Publicado: (2012)

Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease
por: Koh, Carolina Cattoni, et al.
Publicado: (2023)

Acute micro-outbreak of Chagas disease in the southeastern Amazon: a report of five cases
por: de Brito, Andreza Karoline Souza Barros, et al.
Publicado: (2022)

Pathophysiology and new targets for therapeutic options in Chagas heart disease
por: Ferreira, João Marcos B Barbosa
Publicado: (2022)

Chagas Disease
por: Tustin, Aaron W., et al.
Publicado: (2016)

The translational challenge in Chagas disease drug development
por: Kratz, Jadel M, et al.
Publicado: (2022)

Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi
por: Mazzeti, Ana Lia, et al.
Publicado: (2019)

Cholinergic Regulation of Hippocampal Theta Rhythm
por: Gu, Zhenglin, et al.
Publicado: (2022)

Timing of Pharyngeal Swallow Events in Chagas’ Disease
por: dos Santos, Carla Manfredi, et al.
Publicado: (2014)

Sleep pattern and learning in knockdown mice with reduced cholinergic neurotransmission
por: Queiroz, C.M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_taldrl08elcncur4ofbsqre63t